T1	Participants 0 39	Outcome assessment for clinical trials:
T2	Participants 49 61	adjudicators
T3	Participants 370 420	adjudication committee in a large randomized trial
T4	Participants 453 486	potentially operable lung cancer.
T5	Participants 487 522	Up to five independent adjudicators
T6	Participants 638 646	Patients
T7	Participants 1367 1374	patient
